Annual Cash & Cash Equivalents:
$183.58M+$75.63M(+70.05%)Summary
- As of today, KNSA annual cash & cash equivalents is $183.58 million, with the most recent change of +$75.63 million (+70.05%) on December 31, 2024.
- During the last 3 years, KNSA annual cash & cash equivalents has risen by +$61.11 million (+49.90%).
- KNSA annual cash & cash equivalents is now at all-time high.
Performance
KNSA Cash and Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Quarterly Cash & Cash Equivalents:
$307.78M+$39.44M(+14.70%)Summary
- As of today, KNSA quarterly cash & cash equivalents is $307.78 million, with the most recent change of +$39.44 million (+14.70%) on June 30, 2025.
- Over the past year, KNSA quarterly cash & cash equivalents has increased by +$89.02 million (+40.70%).
- KNSA quarterly cash & cash equivalents is now -15.54% below its all-time high of $364.39 million, reached on September 30, 2020.
Performance
KNSA Quarterly Cash & Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
Earnings dates
Cash and Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
KNSA Cash and Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1Y1 Year | +70.0% | +40.7% |
| 3Y3 Years | +49.9% | +122.7% |
| 5Y5 Years | +291.2% | +21.9% |
KNSA Cash and Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs HighAnnual vs High | Annual vs LowAnnual vs Low | Quarter. vs HighQuarter. vs High | Quarter. vs LowQuarter. vs Low | |
|---|---|---|---|---|---|
| 3Y | 3-Year | at high | +70.0% | at high | +66.4% |
| 5Y | 5-Year | at high | +291.2% | -15.5% | +122.7% |
| All-Time | All-Time | at high | +303.0% | -15.5% | +574.1% |
KNSA Cash and Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2025 | - | $307.78M(+14.7%) |
| Mar 2025 | - | $268.34M(+10.1%) |
| Dec 2024 | $183.58M(+70.1%) | $243.63M(+8.9%) |
| Sep 2024 | - | $223.78M(+2.3%) |
| Jun 2024 | - | $218.76M(+2.4%) |
| Mar 2024 | - | $213.55M(+3.5%) |
| Dec 2023 | $107.95M(-12.0%) | $206.37M(+2.6%) |
| Sep 2023 | - | $201.08M(+8.7%) |
| Jun 2023 | - | $184.99M(-1.3%) |
| Mar 2023 | - | $187.49M(-1.6%) |
| Dec 2022 | $122.72M(+0.2%) | $190.61M(-5.0%) |
| Sep 2022 | - | $200.72M(+45.2%) |
| Jun 2022 | - | $138.21M(-5.1%) |
| Mar 2022 | - | $145.58M(-20.1%) |
| Dec 2021 | $122.47M | $182.20M(-9.0%) |
| Sep 2021 | - | $200.18M(-11.5%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2021 | - | $226.08M(-14.4%) |
| Mar 2021 | - | $264.24M(-18.4%) |
| Dec 2020 | $114.04M(+143.0%) | $323.69M(-11.2%) |
| Sep 2020 | - | $364.39M(+44.4%) |
| Jun 2020 | - | $252.40M(+23.6%) |
| Mar 2020 | - | $204.21M(-12.5%) |
| Dec 2019 | $46.93M(-34.8%) | $233.38M(-9.8%) |
| Sep 2019 | - | $258.75M(-10.0%) |
| Jun 2019 | - | $287.45M(-12.0%) |
| Mar 2019 | - | $326.53M(+6.3%) |
| Dec 2018 | $71.98M(+58.0%) | $307.30M(-9.0%) |
| Sep 2018 | - | $337.86M(-6.0%) |
| Jun 2018 | - | $359.45M(+62.5%) |
| Mar 2018 | - | $221.21M(+384.5%) |
| Dec 2017 | $45.55M(-18.6%) | $45.66M |
| Dec 2016 | $55.97M | - |
FAQ
- What is Kiniksa Pharmaceuticals International, plc annual cash & cash equivalents?
- What is the all-time high annual cash & cash equivalents for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc annual cash & cash equivalents year-on-year change?
- What is Kiniksa Pharmaceuticals International, plc quarterly cash & cash equivalents?
- What is the all-time high quarterly cash & cash equivalents for Kiniksa Pharmaceuticals International, plc?
- What is Kiniksa Pharmaceuticals International, plc quarterly cash & cash equivalents year-on-year change?
What is Kiniksa Pharmaceuticals International, plc annual cash & cash equivalents?
The current annual cash & cash equivalents of KNSA is $183.58M
What is the all-time high annual cash & cash equivalents for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high annual cash & cash equivalents is $183.58M
What is Kiniksa Pharmaceuticals International, plc annual cash & cash equivalents year-on-year change?
Over the past year, KNSA annual cash & cash equivalents has changed by +$75.63M (+70.05%)
What is Kiniksa Pharmaceuticals International, plc quarterly cash & cash equivalents?
The current quarterly cash & cash equivalents of KNSA is $307.78M
What is the all-time high quarterly cash & cash equivalents for Kiniksa Pharmaceuticals International, plc?
Kiniksa Pharmaceuticals International, plc all-time high quarterly cash & cash equivalents is $364.39M
What is Kiniksa Pharmaceuticals International, plc quarterly cash & cash equivalents year-on-year change?
Over the past year, KNSA quarterly cash & cash equivalents has changed by +$89.02M (+40.70%)